Natale is at the forefront of the advancement of treatment of Atrial Fibrillation, leading numerous clinical trials and participating in the development of new technologies and procedures. He has received a patent for a device used to modify part of the heart that causes Atrial Fibrillation, and has written or co-written hundreds of published studies on pacing and electrophysiology. Most recently, Natale participated in a clinical trial that supports the increasing use of a procedure called pulmonary-vein isolation to treat Atrial Fibrillation in patients with congestive heart failure. An article reporting the findings of the clinical trial was published in the New England Journal of Medicine.
Natale was head of the Cardiac Electrophysiology Section in the Cardiovascular Medicine Department at the Cleveland Clinic from 1999 to 2007. In 2006, he was named to the Food and Drug Administration's Task Force on Atrial Fibrillation.
Natale graduated from the Medical School of the University of Firenze, Italy, in 1985. After graduating from the Catholic
In addition to Natale, the team of electrophysiologists with the Texas Cardiac Arrhythmia physician group and TCAI includes J. David Burkhardt, M.D.; Shane M. Bailey, M.D.; Robert C. Canby, M.D., F.A.C.C.; Rodney P. Horton M.D.; G. Joseph Gallinghouse, M.D.; Larry D. Price, D.O.; Javier E. Sanchez, M.D.; and Jason D. Zagrodzky, M.D.
|SOURCE Texas Cardiac Arrhythmia Institute|
Copyright©2009 PR Newswire.
All rights reserved